Literature DB >> 19601906

Composition and functions of the influenza fusion peptide.

Karen J Cross1, William A Langley, Rupert J Russell, John J Skehel, David A Steinhauer.   

Abstract

Fusion of the influenza virus envelope with the endosomal membrane of host cells is mediated by the hemagglutinin glycoprotein (HA). The most conserved region of HA is at the N-terminus of the HA2 subunit, a relatively hydrophobic sequence of amino acids referred to as the fusion peptide. This domain is critical both for setting the trigger for fusion and for destabilizing target membranes during the fusion process. The "trigger" is set by cleavage of the HA precursor polypeptide, when the newly-generated HA2 N-terminal fusion peptide positions itself into the trimer interior and makes contacts with ionizable residues to generate a fusion competent neutral pH structure. This essentially "primes" the HA such that subsequent acidification of the endosomal environment can induce the irreversible conformational changes that result in membrane fusion. A key component of these acid-induced structural rearrangements involves the extrusion of the fusion peptide from its buried position and its relocation to interact with the target membrane. The role of the fusion peptide for both priming the neutral pH structure and interacting with cellular membranes during the fusion process is discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19601906     DOI: 10.2174/092986609788681715

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  50 in total

1.  The influenza hemagglutinin fusion domain is an amphipathic helical hairpin that functions by inducing membrane curvature.

Authors:  Sean T Smrt; Adrian W Draney; Justin L Lorieau
Journal:  J Biol Chem       Date:  2014-11-14       Impact factor: 5.157

2.  The complete influenza hemagglutinin fusion domain adopts a tight helical hairpin arrangement at the lipid:water interface.

Authors:  Justin L Lorieau; John M Louis; Ad Bax
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-02       Impact factor: 11.205

3.  Structural changes in Influenza virus at low pH characterized by cryo-electron tomography.

Authors:  Juan Fontana; Giovanni Cardone; J Bernard Heymann; Dennis C Winkler; Alasdair C Steven
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

4.  The influenza fusion peptide adopts a flexible flat V conformation in membranes.

Authors:  Sébastien Légaré; Patrick Lagüe
Journal:  Biophys J       Date:  2012-05-15       Impact factor: 4.033

5.  An antibody directed against the fusion peptide of Junin virus envelope glycoprotein GPC inhibits pH-induced membrane fusion.

Authors:  Joanne York; Jody D Berry; Ute Ströher; Qunnu Li; Heinz Feldmann; Min Lu; Meg Trahey; Jack H Nunberg
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

6.  pH-triggered, activated-state conformations of the influenza hemagglutinin fusion peptide revealed by NMR.

Authors:  Justin L Lorieau; John M Louis; Charles D Schwieters; Adriaan Bax
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

Review 7.  Targeting B cell responses in universal influenza vaccine design.

Authors:  Kaval Kaur; Meghan Sullivan; Patrick C Wilson
Journal:  Trends Immunol       Date:  2011-09-21       Impact factor: 16.687

8.  A transmembrane domain and GxxxG motifs within L2 are essential for papillomavirus infection.

Authors:  Matthew P Bronnimann; Janice A Chapman; Chad K Park; Samuel K Campos
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

9.  The Stabilities of the Soluble Ectodomain and Fusion Peptide Hairpins of the Influenza Virus Hemagglutinin Subunit II Protein Are Positively Correlated with Membrane Fusion.

Authors:  Ahinsa Ranaweera; Punsisi U Ratnayake; David P Weliky
Journal:  Biochemistry       Date:  2018-09-05       Impact factor: 3.162

10.  Fusion peptides promote formation of bilayer cubic phases in lipid dispersions. An x-ray diffraction study.

Authors:  Boris G Tenchov; Robert C MacDonald; Barry R Lentz
Journal:  Biophys J       Date:  2013-03-05       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.